COSCIENS Biopharma Inc. (CSCI) — Cash Flow Quality Index
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow Quality Index of 1.83x as of September 2022. Operating cash flow of $1.06 Million exceeds net income of $576.57K, indicating high earnings quality where cash backs reported profits. Explore COSCIENS Biopharma Inc. (CSCI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
COSCIENS Biopharma Inc. Cash Flow Quality Index (2002–2022)
Historical Cash Flow Quality Index for COSCIENS Biopharma Inc. across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CSCI cash generation efficiency.
Annual Cash Flow Quality Index for COSCIENS Biopharma Inc. (2002–2022)
Year-by-year earnings quality comparison for COSCIENS Biopharma Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.52x | $5.23 Million | $3.45 Million | ▲ +45.4% |
| 2021 | 1.04x | $2.75 Million | $2.64 Million | ▼ -56.5% |
| 2020 | 2.40x | $3.49 Million | $1.46 Million | ▲ +77.8% |
| 2016 | 1.35x | $3.63 Million | $2.69 Million | ▲ +66.8% |
| 2015 | 0.81x | $2.87 Million | $3.55 Million | ▼ -39.6% |
| 2014 | 1.34x | $1.84 Million | $1.37 Million | ▼ -51.9% |
| 2013 | 2.79x | $460.21K | $165.11K | ▲ +99.2% |
| 2011 | 1.40x | $791.62K | $565.69K | ▲ +35.3% |
| 2010 | 1.03x | $479.50K | $463.65K | ▲ +547.8% |
| 2003 | 0.16x | $54.42K | $340.88K | ▲ +120.3% |
| 2002 | -0.79x | $-57.75K | $73.54K | — |